Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
26.36
+0.59 (2.29%)
Dec 20, 2024, 4:00 PM EST - Market closed
Pfizer Revenue
Pfizer had revenue of $17.70B in the quarter ending September 29, 2024, with 31.20% growth. This brings the company's revenue in the last twelve months to $59.38B, down -14.29% year-over-year. In the year 2023, Pfizer had annual revenue of $58.50B, down -41.70%.
Revenue (ttm)
$59.38B
Revenue Growth
-14.29%
P/S Ratio
2.51
Revenue / Employee
$674,716
Employees
88,000
Market Cap
149.38B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 58.50B | -41.83B | -41.70% |
Dec 31, 2022 | 100.33B | 19.04B | 23.43% |
Dec 31, 2021 | 81.29B | 39.64B | 95.16% |
Dec 31, 2020 | 41.65B | 746.00M | 1.82% |
Dec 31, 2019 | 40.91B | 80.00M | 0.20% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sanofi | 54.03B |
Novartis AG | 49.94B |
Bristol-Myers Squibb Company | 47.44B |
Thermo Fisher | 42.37B |
Abbott Laboratories | 41.22B |
Amgen | 32.53B |
Danaher | 23.74B |
Stryker | 21.97B |
PFE News
- 1 day ago - U.S. FDA Approves Pfizer's BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer - Business Wire
- 2 days ago - Pfizer Invites Public to View and Listen to Webcast of February 4 Conference Call with Analysts - Business Wire
- 2 days ago - Roam For the Holidays: Grindr Offers Free Access to Their Popular Travel Feature - Business Wire
- 3 days ago - Pfizer Momentum Shift Makes Me Less Bullish (Technical Analysis) - Seeking Alpha
- 3 days ago - Is Pfizer Stock Undervalued? - Forbes
- 4 days ago - Stock Of The Day: Is Pfizer About To Break Out? Expect A New Uptrend If Resistance Breaks - Benzinga
- 4 days ago - Pfizer Inc. (PFE) Full-Year 2025 Financial Guidance Conference Call (Transcript) - Seeking Alpha
- 4 days ago - Pfizer Stock Rises as 2025 Outlook in Line With Expectations - Investopedia